Identification and localization of heparin-binding region of snake venom VEGF and its blocking of VEGF-A165

4Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Vascular endothelial growth factor (VEGF-A165) displays diverse effects through binding to its receptor, KDR (kinase domain-containing receptor). Heparan sulfate/heparin-like molecules greatly contribute to their interaction. Indeed, the mitogenic potency of VEGF-A165 lacking the C-terminal heparin-binding region is less than 1% compared with intact VEGF-A165. We previously found novel heparin-binding VEGFs, designated VEGF-F that specifically recognizes KDR in snake venoms. VEGF-Fs almost completely lack the C-terminal heparin-binding region compared with VEGF-A165, despite their heparin-binding potential. In this study, we attempted to identify the heparin-binding region of VEGF-F using synthetic peptides. We have demonstrated that the heparin-binding site of VEGF-F is located in its C-terminal region, particularly localized on the N-terminal portion of this region. Furthermore, a synthetic peptide of this region blocks the biological activity of VEGF-A165 in vitro and in vivo. Copyright © 2005 S. Karger AG.

Cite

CITATION STYLE

APA

Tokunaga, Y., Yamazaki, Y., & Morita, T. (2006). Identification and localization of heparin-binding region of snake venom VEGF and its blocking of VEGF-A165. In Pathophysiology of Haemostasis and Thrombosis (Vol. 34, pp. 194–196). https://doi.org/10.1159/000092422

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free